Showing results (71-80 of 138) with videos related to
Sort By:
Pageof 14
Journal of Comparative Effectiveness Research|October 25, 2021
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophyPerry B Shieh, Gary Elfring, Panayiota Trifillis, et al.Neuromuscular Disorders : NMD|November 2, 2019
Large in-frame 5' deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literatureElizabeth M Gibbs, Florian Barthélémy, Emilie D Douine, et al.Journal of Comparative Effectiveness Research|February 7, 2023
Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional statusCraig M McDonald, Jessica R Marden, Perry B Shieh, et al.Muscle & Nerve|January 27, 2021
Safety and efficacy of nusinersen in spinal muscular atrophy: The EMBRACE studyGyula Acsadi, Thomas O Crawford, Wolfgang Müller-Felber, et al.Antimicrobial Agents and Chemotherapy|September 19, 2000
Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazoleS C Lee, C P Fung, J S Huang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implicationsD J Kwiatkowski, D H Harpole, J Godleski, et al.Journal of Neuromuscular Diseases|November 11, 2025
Trach and treat: Safety and motor outcomes following onasemnogene abeparvovec in patients with spinal muscular atrophy and tracheostomies in the RESTORE registryYasemin Erbaş, Laurent Servais, Perry B Shieh, et al.British Journal of Cancer|December 22, 2004
H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cellsC Li, R-H Teng, Y-C Tsai, et al.Muscle & Nerve|October 11, 2019
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trialsCraig M McDonald, Gautam Sajeev, Zhiwen Yao, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2025
Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trialSarah P Sherlock, Daniel I Levy, Avery McIntosh, et al.Pageof 14